🇺🇸 FDA
Pipeline program

GTX-104

GTX-104-003

Phase 3 small_molecule active

Quick answer

GTX-104 for Aneurysmal Subarachnoid Hemorrhage (aSAH) is a Phase 3 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Aneurysmal Subarachnoid Hemorrhage (aSAH)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials